A carregar...
CEACAM6 Is a Novel Biomarker in Pancreatic Adenocarcinoma and PanIN Lesions
OBJECTIVE: The purpose of this study was to test the hypothesis that CEACAM6 expression is an indicator of adverse pathologic features and clinical outcome in pancreatic adenocarcinoma. SUMMARY BACKGROUND DATA: Previously, we have demonstrated carcinoembryonic antigen–related cell adhesion molecule...
Na minha lista:
| Main Authors: | , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2005
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1356989/ https://ncbi.nlm.nih.gov/pubmed/15729073 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/01.sla.0000154455.86404.e9 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|